imiquimod has been researched along with catechin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Dunton, C; Mayeaux, EJ | 1 |
| Langley, PC | 1 |
| Gormley, RH; Kovarik, CL | 1 |
| Scheinfeld, N | 1 |
| Fang, F; Liu, X; Mei, L; Wang, H; Zhang, S | 1 |
| Ballesteros, J; Calzavara-Pinton, P; Hercogová, J; Lynde, CW; Rotaru, M; Schöfer, H; Skerlev, M; Tatti, S | 1 |
| Cavezza, S; Liu, X; Mounsey, K; Ni, G; Pan, X; Wang, T; Yuan, J | 1 |
| Adame, S; Adhami, VM; Babatunde, AS; Bharali, DJ; Chamcheu, JC; Esnault, S; Longley, BJ; Massey, RJ; Mousa, SA; Mukhtar, H; Siddiqui, IA; Wood, GS | 1 |
| Agim, NG; Chamseddin, BH; Jarin, J; Mir, A; Wilson, EE | 1 |
| Barton, S; Edwards, S; O'Mahony, C; Wakefield, V | 1 |
| Biedermann, T; Frasheri, L; Mikschl, P; Schielein, MC; Tizek, L; Zink, A | 1 |
7 review(s) available for imiquimod and catechin
| Article | Year |
|---|---|
Modern management of external genital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Camellia sinensis; Catechin; Condylomata Acuminata; Female; Humans; Imiquimod; Keratolytic Agents; Phytotherapy; Podophyllotoxin | 2008 |
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts | 2012 |
Update on the treatment of genital warts.
Topics: Abnormalities, Drug-Induced; Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Animals; Carcinogenicity Tests; Catechin; Clinical Trials as Topic; Condylomata Acuminata; Dermatologic Agents; Electrocoagulation; Female; Genital Diseases, Female; Genital Diseases, Male; Glycyrrhizic Acid; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hyperthermia, Induced; Imiquimod; Immunotherapy; Incidence; Male; Mice; Mice, Transgenic; Papillomavirus Vaccines; Photochemotherapy; Phytotherapy; Prevalence; Secondary Prevention; United States | 2013 |
Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Catechin; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Male; Papillomavirus Infections; Plant Extracts; Tea; Treatment Outcome | 2017 |
Genital warts treatment: Beyond imiquimod.
Topics: Administration, Topical; Anus Diseases; Catechin; Condylomata Acuminata; Drug Therapy, Combination; Humans; Imiquimod; Interferon Inducers; Interleukin-10; Papillomaviridae; Recurrence; Treatment Outcome | 2018 |
Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis.
Topics: Administration, Topical; Antineoplastic Agents; Anus Diseases; Catechin; Caustics; Condylomata Acuminata; Cryosurgery; Electrosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Laser Therapy; Male; Network Meta-Analysis; Papillomaviridae; Podophyllotoxin; Treatment Outcome; Trichloroacetic Acid | 2019 |
Great green tea ingredient? A narrative literature review on epigallocatechin gallate and its biophysical properties for topical use in dermatology.
Topics: Administration, Topical; Antioxidants; Biophysical Phenomena; Catechin; Cosmetics; Dermatology; Humans; Imiquimod; Plant Extracts; Psoriasis; Tea | 2020 |
5 other study(ies) available for imiquimod and catechin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
A cost-effectiveness analysis of sinecatechins in the treatment of external genital warts.
Topics: Aminoquinolines; Antineoplastic Agents; Camellia sinensis; Catechin; Condylomata Acuminata; Confidence Intervals; Cost-Benefit Analysis; Decision Support Techniques; Drug Utilization; Humans; Imiquimod; Models, Economic; Plant Extracts; Treatment Outcome; United States | 2010 |
Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Topics: Aminoquinolines; Animals; Antioxidants; Body Weight; Catechin; Cytokines; Imiquimod; Inflammation; Mice; Mice, Inbred BALB C; Psoriasis; Skin; Spleen | 2016 |
Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Antioxidants; Catechin; Cell Differentiation; Cells, Cultured; Chitosan; Dermatitis; Filaggrin Proteins; Humans; Imiquimod; Keratinocytes; Mice; Mice, Inbred BALB C; Nanoparticles; Psoriasis | 2018 |
Therapy for anogenital verrucae in preadolescent children with topical and systemic treatment.
Topics: Administration, Topical; Antineoplastic Agents; Antioxidants; Catechin; Child; Child, Preschool; Combined Modality Therapy; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Infant; Male; Retrospective Studies; Treatment Outcome | 2019 |